Back to Search
Start Over
Experimental re-infected cats do not transmit SARS-CoV-2
- Source :
- Emerging Microbes & Infections, article-version (VoR) Version of Record
- Publication Year :
- 2021
- Publisher :
- Cold Spring Harbor Laboratory, 2021.
-
Abstract
- SARS-CoV-2 is the causative agent of COVID-19 and responsible for the current global pandemic. We and others have previously demonstrated that cats are susceptible to SARS-CoV-2 infection and can efficiently transmit the virus to naïve cats. Here, we address whether cats previously exposed to SARS-CoV-2 can be re-infected with SARS-CoV-2. In two independent studies, SARS-CoV-2-infected cats were re-challenged with SARS-CoV-2 at 21 days post primary challenge (DPC) and necropsies performed at 4, 7 and 14 days post-secondary challenge (DP2C). Sentinels were co-mingled with the re-challenged cats at 1 DP2C. Clinical signs were recorded, and nasal, oropharyngeal, and rectal swabs, blood, and serum were collected and tissues examined for histologic lesions. Viral RNA was transiently shed via the nasal, oropharyngeal and rectal cavities of the re-challenged cats. Viral RNA was detected in various tissues of re-challenged cats euthanized at 4 DP2C, mainly in the upper respiratory tract and lymphoid tissues, but less frequently and at lower levels in the lower respiratory tract when compared to primary SARS-CoV-2 challenged cats at 4 DPC. Histologic lesions that characterized primary SARS-CoV-2 infected cats at 4 DPC were absent in the re-challenged cats. Naïve sentinels co-housed with the re-challenged cats did not shed virus or seroconvert. Together, our results indicate that cats previously infected with SARS-CoV-2 can be experimentally re-infected with SARS-CoV-2; however, the levels of virus shed was insufficient for transmission to co-housed naïve sentinels. We conclude that SARS-CoV-2 infection in cats induces immune responses that provide partial, non-sterilizing immune protection against reinfection.
- Subjects :
- 0301 basic medicine
Coronavirus disease 2019 (COVID-19)
Epidemiology
viruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
030106 microbiology
Immunology
Antibodies, Viral
Microbiology
Virus
Cell Line
03 medical and health sciences
Immune system
Antigen
Virology
Chlorocebus aethiops
Drug Discovery
Animals
Medicine
Viral rna
Viral shedding
skin and connective tissue diseases
Vero Cells
re-infection
CATS
SARS-CoV-2
business.industry
Transmission (medicine)
cats
fungi
transmission
COVID-19
General Medicine
Viral Load
Antibodies, Neutralizing
Virus Shedding
body regions
030104 developmental biology
Infectious Diseases
medicine.anatomical_structure
Reinfection
RNA, Viral
Parasitology
Disease Susceptibility
business
Viral load
Research Article
Respiratory tract
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Emerging Microbes & Infections, article-version (VoR) Version of Record
- Accession number :
- edsair.doi.dedup.....77a7d48173ea90fbefc33121d878bcb2
- Full Text :
- https://doi.org/10.1101/2021.01.18.427182